| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Psyence Biomedical Ltd.
13D/A
PBM · 74449F308
|
0% |
5/12/2025
Event 5/2/2025
|
||||
|
Psyence Biomedical Ltd.
13D/A
PBM · 74449F209
|
15.0% |
3/25/2025
Event 3/25/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.